Wakefit IPO Subscription Status – IPO Open

Wakefit IPO subscription status started on Monday December 8, 2025 and will close on December 10, 2025. Wakefit IPO to raise around ₹1,288.89 crores via IPO. The retail quota is 10%, QIB is 75% and NII is 15%. The price band is fixed at ₹185 to ₹195 per equity share.

Table of Contents

The Wakefit IPO minimum market lot is 76 shares with ₹14,820 application amount. The Wakefit IPO is a Mainboard IPO, and it is to be listed on BSE, NSE.

Business Overview

Wakefit Innovations Ltd is one of the leading companies in terms of offering high-quality, affordable home and sleep solutions. It was founded in 2016.

In the mattress category, they have launched innovative products in the past and continue to do so to stand out in the market. Moreover, the company is one of the leading firms because its memory foam mattresses, sold directly to customers online, help keep prices low.

Furthermore, the company has also included more products like pillows, beds, sofas, study tables, wardrobes, and other furniture to meet the needs of modern Indian homes.


IPOWatch View

We recommend investors may apply for an IPO with Long-term Views. Investors should also look at the QIB, NII, and Retail numbers before investing.

Wakefit IPO Subscription Status – Day 1

CategoryDay 1Day 2Day 3
QIB0.000.000.00
NII0.000.000.00
bNII0.000.000.00
sNII0.000.000.00
RII0.000.000.00
Total0.000.000.00


Wakefit IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

Wakefit IPO Review and Rating

  • May Apply For Long-term View

Wakefit IPO Form

How to apply for the Wakefit IPO? You can apply for Wakefit IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Wakefit IPO in the Invest section. The other option is you can apply for Wakefit IPO via IPO forms downloaded online. Check out the Asston Pharmaceuticals forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Wakefit IPO Subscription Status FAQs:


When Wakefit IPO Subscription will start?

The IPO subscription starts on December 8, 2025 for QIB, NII, and Retail Investors.

How to subscribe Wakefit IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live Wakefit IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the Wakefit IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Wakefit IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Wakefit IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *